US Patent Issued to KOREA PHARMA on March 31 for "Jak inhibitor compound and pharmaceutical composition including the same" (South Korean Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,088, issued on March 31, was assigned to KOREA PHARMA Co. LTD. (Hwaseong-si, South Korea).

"Jak inhibitor compound and pharmaceutical composition including the same" was invented by Soosung Kang (Incheon, South Korea), Eun Sun Park (Gwangyang-si, South Korea), Eun Hee Park (Seoul, South Korea) and Seung Hee Han (Suwon-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a JAK inhibitor compound and a pharmaceutical composition including the same. More specifically, the present invention relates to a compound of Formula I or a pharmaceutically acceptable salt thereof and a pharmaceutical composition includi...